Relationship between 13C-aminopyrine breath test and the MELD score and its long-term prognostic use in patients with cirrhosis

Digestive Diseases and Sciences

Volumn 58, Issue 10, 2013, Pages 3024-3028

  Giannini, Edoardo G ^a   Savarino, Vincenzo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Aminopyrine breath test; Cirrhosis; Liver function; MELD score; Prognosis

Indexed keywords

AMINOPHENAZONE; AMINOPHENAZONE C 13; UNCLASSIFIED DRUG; CARBON; DIAGNOSTIC AGENT;

ADULT; AMINOPHENAZONE BREATH TEST; ARTICLE; BREATH ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; ISOTOPE LABELING; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; COHORT ANALYSIS; COMPARATIVE STUDY; END STAGE LIVER DISEASE; EVALUATION STUDY; KAPLAN MEIER METHOD; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL RATE; DIAGNOSTIC USE; PROCEDURES;

AMINOPYRINE; BREATH TESTS; CARBON ISOTOPES; COHORT STUDIES; END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; SURVIVAL RATE;

EID: 84885324299     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2739-1     Document Type: Article

References (35)

1. Jalan R, Hayes PC. Review article: quantitative tests of liver function. Aliment Pharmacol Ther. 1995;9:263-270.
2. Saunders JB, Wright N, Lewis K. Predicting outcome of paracetamol poisoning by using 14-C-aminopyrine breath test. BMJ. 1980;280:279-280.
3. Schneider JF, Baker AL, Haines NW, Hatfield G, Boyer JL. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease. Gastroenterology. 1980;79:1145-1150.
4. Gill RA, Goodman MW, Golfus GR. Aminopyrine breath test predicts surgical risk for patients with liver disease. Ann Surg. 1983;198:701-704.
5. Ecochard M, Boillot O, Guillaud O, Roman S, et al. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients. Clin Transpl. 2011;25:755-765.
6. Wensing G, Sabra R, Branch RA. The onset of sodium retention in experimental cirrhosis in rats is related to a critical threshold of liver function. Hepatology. 1990;11:779-786.
7. Wensing G, Lotterer E, Link I, Hahn EG, Fleig WE. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function. Hepatology. 1997;26:1149-1155.
8. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464-470.
9. Botta F, Giannini E, Romagnoli P, Fasoli A, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated to residual liver function. A European study. Gut. 2003;52:134-139.
10. Degré D, Bourgeois N, Boon N, Le Moine O, et al. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transpl Int. 2004;17:31-38.
11. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding esophageal varices. Br J Surg. 1973;60:646-664.
12. Ghoos Y. 13CO2-Breath Tests at the Laboratory "Digestion- Absorption". eds. University Hospital Gasthuisberg Leuven, Belgium 1996:43-54.
13. Giannini E, Fasoli A, Chiarbonello B, Malfatti F, et al. 13C-aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther. 2002;16:717-725.
14. Fasoli A, Giannini E, Botta F, Romagnoli P, et al. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis. Hepatogastroenterology. 2000;47:234-238.
15. Haycock G, Shwartz G, Wisotsky D. Geometric method for measuring body surface area. J Pediatr. 1978;93:62-66.
16. Herold C, Heinz R, Niedobitek G, Schneider T, Hahn EG, Schuppan D. Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C. Liver. 2001;21:260-265.
17. Giannini EG, Fasoli A, Borro P, Botta F, et al. 13C-galactose breath test and 13C-aminopyrine breath test for the study of liver function in chronic liver disease. Clin Gastroenterol Hepatol. 2005;3:279-285.
18. Rocco A, de Nucci G, Valente G, Compare D, et al. 13C-aminopyrine breath test accurately predicts long-term outcome of chronic hepatitis C. J Hepatol. 2012;56:782-787.
19. Adler M, Van Laethem J, Glibert A, Gelin M, et al. Factors influencing survival at one year in patients with non-biliary hepatic parenchymal cirrhosis. Dig Dis Sci. 1990;35:1-5.
20. Urbain D, Muls V, Thys O, Ham HR. Aminopyrine breath test improves long-term prognostic evaluation in patients with alcoholic cirrhosis in Child classes A and B. J Hepatol. 1995;22:179-183.
21. Urbain D, Muls V, Makhoul E, Jeghers O, Thys O, Ham HR. Prognostic significance of hepatic venous pressure gradient in medically treated alcoholic cirrhosis: comparison to aminopyrine breath test. Am J Gastroenterol. 1993;88:856-859.
22. Henry D, Kitchingman G, Langman MJS. 14-C-Aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis. Dig Dis Sci. 1985;30:813-818.
23. Villeneuve J-P, Infante-Rivard C, Ampelas M, Pomier-Layrargues G, Huet P-M, Marleau D. Prognostic value of the aminopyrine breath test in cirrhotic patients. Hepatology. 1986;6:928-931.
24. Beuers U, Jäger F, Wahlländer A, Ansari H, Kirsch CM. Prognostic value of the intravenous 14-C-aminopyrine breath test compared to the Child-Pugh score and serum bile acids in 84 cirrhotic patients. Digestion. 1991;50:212-218.
25. Merkel C, Gatta A, Zoli M, Bolognesi M, et al. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Dig Dis Sci. 1991;9:1197-1203.
26. Merkel C, Bolognesi M, Bellon S, Bianco S, et al. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut. 1992;33:836-842.
27. Van Thiel DH, Schade RR, Gavaler JS, Shaw BW, Iwatsuki S, Starzl TE. Medical aspects of liver transplantation. Hepatology. 1984;4(795-83):5.
28. Fagiuoli S, Mirante VG, Pompili M, Gianni S, et al. Liver transplantation: the Italian experience. Digest Liver Dis. 2002;34:640-648.
29. Lotterer E, Hogel J, Gaus W, Fleig WE, Bircher J. Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study. Hepatology. 1997;26:1426-1433.
30. 13C] aminopyrine breath test. Dig Dis Sci. 2001;46:133-139.
31. Giannini EG, Malfatti F, Botta F, Polegato S, et al. Influence of 1-week Helicobacter pylori eradication therapy with rabeprazole, clarithromycin, and metronidazole on 13C-aminopyrine breath test. Dig Dis Sci. 2005;50:1207-1213.
32. Giannini EG, Savarino V, Testa R. Monitoring cytochrome P-450 activity during rabeprazole treatment in patients with gastresophageal reflux disease. Dig Dis Sci. 2006;51:1602-1606.
33. Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health. 2000;90:1562-1569.
34. Scarborough JE, Pietrobon R, Marroquin CE, Tuttle-Newhall JE, et al. Temporal trends in early clinical outcomes and health care resource utilization for liver transplantation in the United States. J Gastrointest Surg. 2007;11:82-88.
35. Afolabi P, Wright M, Wootton SA, Jackson AA. Clinical utility of 13C-liver-function breath tests for assessment of hepatic function. Dig Dis Sci. 2013;58:33-41.